| Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II. | |
| | |
MedLine Citation:
|
PMID: 19791425 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003. |
| | |
Authors:
|
Owen O'Connor; John Wright; Craig H Moskowitz; Jamie Muzzy; Barbara MacGregor-Cortelli; Paul Hamlin; David Straus; Elizabeth Trehu; David P Schenkein; Andrew D Zelenetz |
Related Documents
:
|
20448525 - Recent advances in the treatment of t-cell lymphomas. 20198395 - Highlights from the scientific and educational abstracts presented at the aser 2009 ann... 17776465 - Scientific meetings. 21688705 - Ontario: prostitution-related provisions of criminal code struck down. 21702745 - In all questions, my interest is not in the individual people but in the analytic movem... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of the National Comprehensive Cancer Network : JNCCN Volume: 2 Suppl 4 ISSN: 1540-1405 ISO Abbreviation: J Natl Compr Canc Netw Publication Date: 2004 Nov |
Date Detail:
|
Created Date: 2009-10-01 Completed Date: 2009-10-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101162515 Medline TA: J Natl Compr Canc Netw Country: United States |
Other Details:
|
Languages: eng Pagination: S21-2 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Boronic Acids
/
therapeutic use* Humans Lymphoma, Mantle-Cell / drug therapy* Lymphoma, Non-Hodgkin / drug therapy* Protease Inhibitors / therapeutic use* Proteasome Endopeptidase Complex / antagonists & inhibitors* Pyrazines / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Boronic Acids; 0/Protease Inhibitors; 0/Pyrazines; 0/bortezomib; EC 3.4.25.1/Proteasome Endopeptidase Complex |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bortezomib in combination with other therapies for the treatment of multiple myeloma.
Next Document: Intraoperative administration of low-molecular-weight heparins in reconstructive vascular operations